NYU Grossman School of Medicine’s General Surgery Residency in Manhattan provides the skills and expertise needed to ...

AB8939 intellectual property rights in AML are secured until 2036 through a ‘composition of matter’ patent and potentially 2041 with the 5 years extension and until 2044 in AML with chromosome ...

Arcus Biosciences is a 'Buy' with strong trial results, robust pipeline, and key phase 3 news coming. Click here to read an analysis of RCUS stock now.

The USAN, consisting of members from the Food and Drug Administration (FDA), American Medical Association (AMA), United States Pharmacopeia (USP) and the American Pharmacists Association (APhA), is ...

Patients treated with ulixacaltamide in the parallel-group study (Study 1) showed a mean improvement from baseline in the Modified Activities of ...

Agenus Inc. (“Agenus”) (Nasdaq: AGEN ), a leader in immuno-oncology, will host a virtual Stakeholder Briefing on Tuesday, October 21, 2025, at 4:00 p.m. ET. The webcast will f ...

India's youngest billionaires are changing the nation's economy. These entrepreneurs, aged 31 and under, are making their ...

Detailed price information for Dianthus Therapeutics Inc (DNTH-Q) from The Globe and Mail including charting and trades.

Pennsylvania’s new 10-year roadmap outlines plans for AI, data centers, and energy growth, including regional innovation ...

Oct. 16 is World Food Day, a global campaign to celebrate the founding of the Food and Agriculture Organization 80 years ago, ...

Myeloid Therapeutics has rebranded as Create Medicines and unveiled a drug development strategy adding to its initial emphasis on cancer treatments.

Eight new oncology approvals between July and September 2025 marked a pivotal quarter for cancer treatment[1], as cellular ...